To: High-Tech East who wrote (45309 ) 9/15/2001 4:03:28 PM From: High-Tech East Respond to of 64865 ... just to keep you all up to date <g> Artificial-heart recipient talks day after surgery, Second patient to get test device doing 'fabulously' by Dick Kaukas - The Courier-Journal Tom Christerson, the second man to receive a self-contained artificial heart, already was talking to his family and his physicians at Jewish Hospital in Louisville yesterday -- one day after his surgery. Dr. Laman Gray, who performed the implant with his colleague, Dr. Robert Dowling, said last night that Christerson was doing ''fabulously.'' He cautioned, however, that it was too early to make predictions of long-term success. ''This is a highly experimental procedure, and we have no way of knowing what the end result is going to be,'' Gray said. ''So, while I am delighted so far, and he's doing better than we could have ever expected, I've also got to be realistic because I know how sick'' Christerson was before the surgery. "It could change day by day, hour by hour,'' Gray said. The 70-year-old retired businessman from Central City, Ky., was resting comfortably in intensive care, Gray said.Immediately after the surgery, Christerson had been using a ventilator to help him breathe, a common necessity for people who have undergone open-heart surgery. But he was doing well enough to be taken off the machine yesterday, Gray said. Christerson's five-hour operation Thursday marked the second time that University of Louisville surgeons have removed a patient's failing heart and replaced it with a plastic and metal pump called the AbioCor. Made by Abiomed, a Massachusetts company, the device was first used on July 2 when the same medical team, led by Gray and Dowling, attached it in the chest of Robert Tools, 59, a retired technical librarian from Franklin, Ky. Tools has been making steady progress and recently was moved from intensive care into a ''transitional monitoring'' area of the hospital. Christerson's cardiologist, Dr. Geetha Bhat, agreed with Gray yesterday that ''so far everything looks OK.'' She added, however, that ''it's still very early after surgery,'' and that complications could still occur. Bhat concluded, ''His condition is stable.'' Abiomed announced in January that the federal Food and Drug Administration had given permission for the AbioCor to be implanted in five patients, all of them with heart failure so severe they had an estimated 30 days or less to live. Gray said that Christerson's heart failure was as severe as Tools' was, but that he had not been sick for as long as Tools and had not lost as much weight or become as weak. Abiomed is working with five medical centers, but Jewish has had the first two implants. The AbioCor is run by electricity, but it has no cables or wires connecting to an external power source. Instead, the heart uses a system that transmits power from an external coil through the skin to an implanted receiving device that connects to the heart and keeps it pumping. Heart-implant patient Tom Christerson, left, ''is doing better than we could have ever expected,'' Dr. Laman Gray said.courier-journal.com